Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04770922 · ClinicalTrials.gov registry record
Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia
A clinical trial of Acute Lymphoblastic Leukemia, Pediatric and Adverse Drug Event, sponsored by Cipherome.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT04770922 is a study of Acute Lymphoblastic Leukemia, Pediatric and Adverse Drug Event that has completed, run by Cipherome. The registered enrollment target is 80 participants, below the 114-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04770922, a study of Acute Lymphoblastic Leukemia, Pediatric and Adverse Drug Event, has completed, sponsored by Cipherome.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective biobank study evaluating the impact of novel genetic variants in a population of 6-mercaptopurine treated pediatric acute lymphoblastic leukemia patients.
Conditions Studied
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-02-23 |
| Est. Completion | 2021-11-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04770922
The ClinicalTrials.gov registry entry for NCT04770922 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 114-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (30% lower). The listed sponsor is Cipherome, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Lymphoblastic Leukemia, Pediatric appearing as the primary indexed condition, and to 0 interventions.
NCT04770922 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04770922 about?
NCT04770922 is a clinical study titled "Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia". This is a retrospective biobank study evaluating the impact of novel genetic variants in a population of 6-mercaptopurine treated pediatric acute lymphoblastic leukemia patients.
What is the current status of trial NCT04770922?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2021-02-23. Estimated completion is 2021-11-10.
What conditions does trial NCT04770922 study?
This clinical trial studies the following conditions: Acute Lymphoblastic Leukemia, Pediatric, Adverse Drug Event.
Who is sponsoring clinical trial NCT04770922?
This trial is sponsored by Cipherome, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04770922 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Lymphoblastic Leukemia, Pediatric
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
RECRUITING · NA
-
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
RECRUITING · Phase 1
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
-
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
RECRUITING · NA
-
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Acute Lymphoblastic Leukemia, Pediatric
All registered trials for this condition
Adverse Drug Event
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.